Chemical Industry News, Data & Insights

KEYTRUDA QLEX, a subcutaneous immune checkpoint inhibitor, offers comparable efficacy to IV KEYTRUDA in treating metastatic NSCLC, with administration possible in one minute by healthcare providers.

Sasol seeks a court ruling on emission targets in the Highveld Air Quality Plan, aiming for legal clarity while maintaining commitment to air quality goals.

ENFLONSIA™ awaits EU approval for infant RSV prevention, offering a single-dose option for all weights. Backed by Phase 2b/3 and Phase 3 trials, decision expected by year-end.

CHMP backs KEYTRUDA SC for all EU adult indications and a new use in LA-HNSCC. Awaiting European Commission's final decision.

The sale of Datteln 4, a modern coal plant, is part of EU state aid conditions. Regulatory approvals are pending. Purchase price undisclosed.

The merger aims to streamline operations and cut costs. Effective December 1, 2025, all assets and commitments will transfer, with no impact on existing business relations.

Investing in LFP and drone batteries, ASPİLSAN enhances R&D and production, promoting battery tech awareness and a fully integrated value chain in Turkey.